Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seccombe, D. W.
Right arrow Articles by Booth, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seccombe, D. W.
Right arrow Articles by Booth, F.
NEUROLOGY 1986;36:264
© 1986 American Academy of Neurology

L-Carnitine treatment in glutaric aciduria type I

D. W. Seccombe, L. James and F. Booth

Department of Pathology (Drs. Seccombe and James), University of British Columbia and Shaughnessy Hospital, Lipid Research Group, Vancouver, British Columbia, Canada; and the Department of Pediatrics (Dr. Booth), University of Manitoba and Children's Hospital, Winnipeg, Manitoba, Canada.

Patients with organic aciduria may have a higher than normal requirement for L-carnitine. In a patient with type I glutaric aciduria, serum total L-carnitine levels were 8.5 µM (normal, 54.4 ± 14.2 [2 SD] µM). After treatment with L-carnitine for 1 month, serum levels of both free and total L-carnitine were normal with an acyl-to-total ratio of 0.18. The fractional clearance rates of free and acylcarnitine were increased fourfold by treatment. Acetylcarnitine accounted for a lower than normal percentage of acylcarnitine recovered in serum and urine. Data suggest that this patient may have been carnitine-deficient.

Address correspondence and reprint requests to Dr. Seccombe, Department of Pathology, Shaughnessy Hospital, 4500 Oak Street, Vancouver, BC, Canada V6H 3N1.

Supported by a grant from the British Columbia Health Care Research Foundation. L. James was supported on this project by a B.C. Heart Studentship.

Accepted for publication May 30, 1985.




This article has been cited by other articles:


Home page
NeurologyHome page
M. Samuraki, K. Komai, Y. Hasegawa, M. Kimura, S. Yamaguchi, N. Terada, and M. Yamada
A SUCCESSFULLY TREATED ADULT PATIENT WITH l-2-HYDROXYGLUTARIC ACIDURIA
Neurology, March 25, 2008; 70(13): 1051 - 1052.
[Full Text] [PDF]


Home page
J Child NeurolHome page
Y. Awaad, H. Shamato, and H. Chugani
Hemidystonia Improved by Baclofen and PET Scan Findings in a Patient With Glutaric Aciduria Type I
J Child Neurol, March 1, 1996; 11(2): 167 - 169.
[PDF]


Home page
J Child NeurolHome page
P. T. Ozand and G. G. Gascon
Topical Review Article: Organic Acidurias: A Review Part 2
J Child Neurol, October 1, 1991; 6(4): 288 - 303.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.